Isomerase
EMEA
Cambridge
,
United Kingdom
Established
FOUNDED
2012
HEADCOUNT
21-100
FUNDING
Privately held
Keywords:
CRO, CDMO, metabolic_engineering, synthetic_biology, enzymes, AI/ML, therapeutics
BUSINESS
Isomerase Therapeutics, founded in 2012 and based at Chesterford Research Park near Cambridge, UK, is a biotechnology CRO specializing in microbial engineering for natural products discovery, recombinant peptide production, and biocatalytic enzyme development. The company serves clients across pharma, agritech, consumer goods, food/ingredients, and chemical manufacturing on fee-for-service, FTE, or consultancy models
BIOTECH INVOLVEMENT
Core; Cambridge, UK CDMO/CRO (2012) for microbial strain engineering, enzyme discovery, and biosynthetic production of natural products, peptides, and therapeutics; runs synthetic biology and fermentation in-house.
TECHNOLOGY PLATFORM
microbial strain engineering; enzyme engineering; ML-guided optimization; biosynthetic pathways
PRIMARY PRODUCTS
Custom enzymes; microbial natural products; recombinant proteins; bioproduction services